Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
FEBS J. 2019 Oct;286(20):3946-3958. doi: 10.1111/febs.15056. Epub 2019 Sep 18.
The dysregulation of ubiquitin-mediated proteasomal degradation has emerged as an important mechanism of pathogenesis in several cancers. The speckle-type POZ protein (SPOP) functions as a substrate adaptor for the cullin3-RING ubiquitin ligase and controls the cellular persistence of a diverse array of protein substrates in hormone signalling, epigenetic control and cell cycle regulation, to name a few. Mutations in SPOP and the resulting dysregulation of this proteostatic pathway play causative roles in the pathogenesis of prostate and endometrial cancers, whereas overexpression and mislocalization are associated with kidney cancer. Understanding the molecular mechanism of the normal function of SPOP as well as the cause of SPOP-mediated oncogenesis is thus critical for eventual therapeutic targeting of SPOP and other related pathways. Here, we will review SPOP structure, function and the molecular mechanism of how this function is achieved. We will then review how mutations and protein mislocalization contribute to cancer pathogenesis and will provide a perspective on how SPOP may be targeted therapeutically.
泛素介导的蛋白酶体降解失调已成为多种癌症发病机制的一个重要机制。斑点型 POZ 蛋白 (SPOP) 作为 cullin3-RING 泛素连接酶的底物衔接子发挥作用,控制多种蛋白底物在激素信号、表观遗传控制和细胞周期调节中的细胞持久性,仅举几例。SPOP 的突变及其导致的这种蛋白质稳态途径的失调在前列腺癌和子宫内膜癌的发病机制中起着因果作用,而过表达和定位错误与肾癌有关。因此,了解 SPOP 的正常功能的分子机制以及 SPOP 介导的致癌作用的原因,对于最终针对 SPOP 和其他相关途径进行治疗性靶向至关重要。在这里,我们将回顾 SPOP 的结构、功能以及实现这一功能的分子机制。然后,我们将回顾突变和蛋白质定位错误如何导致癌症发病机制,并提供关于如何进行 SPOP 治疗性靶向的观点。